Sotatercept for Patients Not Reaching Low Risk / Dae-Hee Kim (Univ. of Ulsan, Korea) Paradigm Shift in PAH Treatment and Role of Sotatercept / John Feenstra (Pulmonary Hypertension Research Queensland, Australia) Sotatercept Position in Guidelines and How Does It Really Work / Soo Yong Lee (Pusan National Univ., Korea) Who Would Benefit from ASI / Sotatercept in Korea? (Deep dive into CTD-PAH) / Jina Yeo (Gachon Univ., Korea) | 
